Broker gives its verdict on the CSL share price post-FY22 results

Here's what this broker is saying about the CSL share price…

| More on:
Broker looking at the share price on her laptop with green and red points in the background.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The CSL Limited (ASX: CSL) share price was out of form on Wednesday.

The biotherapeutics company's shares fell as much as 6% before recovering to end the day 1.5% lower at $292.50.

This followed the release of a full year result that met expectations but included guidance for FY 2023 that fell short of what the market was expecting.

Is the CSL share price pullback a buying opportunity?

According to a note out of Goldman Sachs, its analysts aren't ready to press the buy button just yet.

This morning the broker retained its neutral rating with a trimmed price target of $291.00.

This is broadly in line with where the CSL share price is trading today.

What did the broker say?

Goldman highlights that the CSL Behring business was the driver of its weaker than expected guidance for FY 2023. It commented:

Plasma collections grew +24% in FY22 (from +18% in 1H22), and whilst this acceleration was widely expected, it underpins the volume recovery through FY23-24E. However, the updates on Behring costs/margins were less assured and were the primary driver of FY23 NPAT guidance falling (3)-(7)% below consensus today (despite another strong performance from Seqirus).

And while the broker suspects that management could be being conservative with its guidance, it also believes it is a reminder that the company is not out of the woods just yet.

On both fronts, CSL would have applied at least its typical dose of conservatism but management now sees the trough in Behring gross margins as 1H23 (from 2H22 previously), a timing-driven downgrade but a material one, reminding investors that the industry is not out of the woods (2H22 margins of 52.5% are -531bps below pre-Covid levels). Staffing pressures and collections costs will remain key challenges through the mid-term, but we see enough tailwinds to drive a sequential improvement from 2H23 (primarily price/mix and improved fixed cost absorption, but also some modest benefit from Rika). Overall, we revise Behring EBIT forecasts by -15%/-2%/-1% through FY23-25E.

All in all, the broker appears to believe investors should wait for the CSL share price to pullback a little more before making a move.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

woman holding her baby and looking at her phone happy at the rising share price
Broker Notes

3 ASX All Ords shares that brokers tip will grow 30% to 40% this year

The experts say these three ASX All Ords stocks have great growth ahead of them.

Read more »

Smiling couple looking at a phone at a bargain opportunity.
Cheap Shares

2 'materially undervalued' ASX 200 shares to buy while they're at 'attractive value'

Is there a better feeling in investing than grabbing stocks for cheap then watching while everyone else catches on to…

Read more »

A man sees some good news on his phone and gives a little cheer.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

A young man sits at his desk working on his laptop with a big smile on his face due to his ASX shares going up and in particular the Computershare share price
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man in suit and tie is smug about his suitcase bursting with cash.
Broker Notes

These ASX shares could rise 20% to 50%

Analysts see a lot of value in these buy-rated shares.

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news about interest rates rising and one expert's surprising recommendation as to which ASX shares to buy
Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Jess Amir
Investing Strategies

Wake up! 3 stocks to watch RIGHT NOW

This trio could be in for a huge few days. Moomoo's Jessica Amir explains why and how.

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »